Active Funding Opportunity Announcements (FOAs) for All NICHD

NICHD issues and participates in various FOAs to support research activities and training.

Investigator-Initiated (Unsolicited) Projects

To submit unsolicited or investigator-initiated applications, use the appropriate NIH Parent Announcement.

Active FOAs for NICHD

Please note: The following FOAs are sorted by date, from most recent to oldest. Select a table heading to change how to sort and display the FOAs.

Announcement Number Submissions Date(s) Sort descending Expiration Date Activity Code(s) Title
PA-16-287 May 26, 2019 333 Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Admin Supp)
RFA-OD-19-011 May 26, 2019 T32 Predoctoral Training in Advanced Data Analytics for Behavioral and Social Sciences Research (BSSR) - Institutional Research Training Program [T32]
PAR-18-745 June 14, 2018, November 14, 2018, June 14, 2019, November 14, 2019, June 15, 2020 and November 13, 2020 by 5:00 PM local time of applicant organization. November 14, 2020 R21 Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R21 Clinical Trial Optional)
RFA-NS-18-042 November 27, 2018; February 11, 2019; July 11,2019; November 12 , 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
November 13, 2019 R21 Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R21 Clinical Trial Not Allowed)
RFA-NS-18-041 November 27, 2018; March 7, 2019; November 25, 2019; March 12, 2020 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. March 13, 2020 R61/R33 Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)
PA-17-478 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.The first standard due date for this FOA is February 5, 2018 January 8, 2021 R01 Research on Transgender Health (R01)
PA-18-590 A change of grantee organization request must be made before the anticipated start date at the new organization and preferably several months in advance. January 26, 2021 777 Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)
PA-16-285 A change of grantee organization request must be made before the anticipated start date at the new organization and preferably several months in advance. May 26, 2019 777 Change of Grantee Organization (Type 7 Parent)
PA-18-589 A successor-in-interest request must be made before the anticipated start date at the new organization and preferably several months in advance. January 26, 2021 666 Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
PA-16-286 A successor-in-interest request must be made before the anticipated start date at the new organization and preferably several months in advance. May 26, 2019 666 Successor-in-Interest (Type 6 Parent)
PAR-18-951 April 15, 2019, April 15, 2020, April 15, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. April 16, 2021 U01 Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)
PAR-18-333 April 4, 2018, December 5, 2018, April 5, 2019, December 5, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
December 6, 2019 R01 Understanding the Early Development of the Immune System (R01 - Clinical Trial Not Allowed)
PAR-18-214 April 4, 2018; August 7, 2018; November 7, 2018; April 4, 2019; August 7, 2019; November 7, 2019; April 3, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. April 4, 2020 R21 Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
PAR-18-215 April 4, 2018; August 7, 2018; November 7, 2018; April 4, 2019; August 7, 2019; November 7, 2019; April 3, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. April 4, 2020 R01 Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
RFA-HD-19-024 April 4, 2019, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.
Only accepting applications for the AIDS Application Due Date(s) listed below.
May 15, 2019 R01 Womens HIV Epidemiology Cohort Studies (R01 Clinical Trial Not Allowed)
PAR-17-237 August 1, 2017; August 17, 2018; August 17, 2019 , by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates . August 18, 2019 P30 Centers for AIDS Research (P30)
PAR-17-238 August 1, 2017; August 17, 2018; August 17, 2019), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. August 18, 2019 P30 Developmental Centers for AIDS Research (P30)
PAR-18-854 August 23, 2018; September 13, 2018; October 10, 2018; November 13, 2018; December 11, 2018; January 10, 2019; February 11, 2019; March 11, 2019; April 11, 2019; May 10, 2019; June 10, 2019; July 11, 2019; August 9, 2019; September 12, 2019; October 11, 2019; November 13, 2019; December 10, 2019; January 10, 2020; February 10, 2020; March 10, 2020; April 7, 2020; May 11, 2020; June 10, 2020; July 10, 2020; August 11, 2020; September 10, 2020; October 14, 2020; November 10, 2020; December 11, 2020; January 11, 2021; February 10, 2021; March 10, 2021; April 9, 2021; May 10, 2021; June 11, 2021; July 9, 2021; August 10, 2021; September 10, 2021 by 5:00 PM local time of applicant organization. September 11, 2021 R01 Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)
PAR-17-187 August 7, 2017; November 7, 2017; April 4, 2018; August 7, 2018; November 7, 2018; April 4, 2019; August 7, 2019; November 7, 2019; April 3, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. April 4, 2020 R21 Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21)
PAR-17-188 August 7, 2017; November 7, 2017; April 4, 2018; August 7, 2018; November 7, 2018; April 4, 2019; August 7, 2019; November 7, 2019; April 3, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. April 4, 2020 R03 Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R03)